fda shortage tirzepatide news confirms is still over, gives compounders a grace period Tirzepatide is NO longer in – Mounjaro and Zepbound Are No – tirzepatide drug shortage list removed

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke GLP-1 receptor agonists such as semaglutide may be able to help reduce the risk of ischemic stroke in patients without diabetes, according to a new meta-analysis of preclinical studies published in Stroke .[1] These drugs have been linked to several key improvements in the cardiovascular health of patients with type 2 diabetes

The medication itself is fully regulated and approved for use

GLP-1 drugs as a class have shown mixed results in heart failure populations

More time and clinical studies are needed to determine whatever long-term health benefits and cost avoidance result from prescribing and covering these drugs for weight loss